UniversityNews & EventsOnline Spotlights
Spitzenforschung in der Künstlichen Intelligenz und personalisierten Medizin – weltweit vernetzt

Cutting-Edge Research in Artificial Intelligence and Personalised Medicine via International Networks

Press release from
Key visual: International Future Labs ("Internationale Zukunftslabore") Key visual: International Future Labs ("Internationale Zukunftslabore") Key visual: International Future Labs ("Internationale Zukunftslabore")
© BMBF

Leibniz University Hannover coordinates future lab with international researchers

Starting in summer 2020, scientists from numerous countries will conduct research on current issues in artificial intelligence (AI) and its applications in personalised medicine within the framework of the International Future Lab for Artificial Intelligence ("LeibnizAILab") - including more accurate diagnoses, individual therapy and personalised medication. In collaboration with leading researchers from Australia, New Zealand, Singapore, India and the United States, renowned colleagues from the L3S Research Centre (Faculty of Electrical Engineering and Computer Science at Leibniz University Hannover and Hannover Medical School) as well as partner institutions in Europe will conduct research on AI and develop intelligent solutions for personalised medicine.

Over the next three years, the project is in receipt of funding from the Federal Ministry of Education and Research (BMBF) amounting to a maximum of five million euros. In addition to the future lab led by Leibniz University Hannover, two projects based in Berlin and Munich have been awarded funding. Overall, 14 proposals were submitted.

"We are delighted about the success of our research concept on developing intelligent, reliable and responsible systems to be used in personalised medicine", says Prof. Dr. Wolfgang Nejdl, managing director of L3S. Personalised medicine focuses on individual therapy as well as customised medication for patients and more accurate diagnoses. For this, enormous amounts of data must be processed and analysed. The new LeibnizAILab intends to establish a central contact point for artificial intelligence and its applications. The project brings together the expertise of researchers from Germany and abroad, enabling them to develop collaborative research and innovation projects taking into account various cultural, social and economic factors. Furthermore, the project fosters guest mobility by offering research visits at L3S in Hannover for a maximum duration of two years.

Through machine learning, LeibnizAILab aims to accelerate diagnostics and drug development while improving individual therapy in order to face social challenges such as demographic change, chronic common diseases as well as rare medical conditions. For example, a team of researchers currently works on developing models for predicting individual hearing success via cochlear implants in a highly accurate manner by integrating relevant data.

L3S Research Centre

L3S is a joint facility of universities in Hannover and Braunschweig and focuses on application-oriented fundamental research in order to develop innovative methods and technologies in the fields of web science, artificial intelligence and digital transformation. The centre conducts fundamental research in an interdisciplinary context and holds a leading position in online development and digital transformation - both nationally and internationally.


Note to editors:

For further information, please contact Prof. Dr. Wolfgang Nejdl, managing director of L3S (Tel. +49 511 762 19710, Email nejdl@L3S.de).